Consegna Group (ASX: CGP) has been granted a trading halt by the ASX today pending an announcement in relation to a capital raising, with the company's shares placed in pre-open.
While Consegna did not release any further details on its capital raising and what the funds may be used for, the company recently reaffirmed its plan for 2012 to seek international licensing deals specifically for the BreatheAssist technology.
BreatheAssist is a multi-functional nasal dilation technology that enhanced nasal airflow by 37% in a clinical study.
Importantly, there are multiple licensing opportunities for BreatheAssist, including sport, medication delivery, snoring cessation, aiding sleep apnoea and the filtration of pollen and other airborne pollutants.
The trading halt will be in effect until an announcement is made to the market or no later than the start of trading on Wednesday, 25 January.